Exelixis (EXEL) Equity Average (2011 - 2026)

Exelixis (EXEL) recorded quarterly Equity Average of $2.0 billion in Q2 2026, down 5.2% quarter-over-quarter from $2.2 billion in Q1 2026, and down 6.36% on a YoY basis from $2.2 billion in Q2 2025.

Exelixis (EXEL) Equity Average (2011 - 2026) Analysis & Trends

Exelixis' Equity Average history runs 16 years deep, the most recent figure standing at $2.0 billion for Q2 2026.

  • In Q2 2026, Equity Average fell 6.36% year-over-year to $2.0 billion; the TTM figure through Apr 2026 stood at $2.0 billion (down 6.36% YoY), while the FY2026 annual figure was $2.2 billion, down 2.28% from the prior year.
  • Equity Average was $2.0 billion for Q2 2026 at Exelixis, down from $2.2 billion in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $2.5 billion in Q2 2023 to a low of $2.0 billion in Q2 2026.
  • Historically, Equity Average has averaged $2.3 billion across 5 years, with a median of $2.3 billion in 2022.
  • The sharpest annual moves came in 2022 and 2024: Equity Average gained 18.84% in 2022, then fell 16.43% in 2024.
  • A 5-year view of Equity Average shows it stood at $2.5 billion in 2022, then retreated by 7.4% to $2.3 billion in 2023, then slipped by 4.69% to $2.2 billion in 2024, then dropped by 4.57% to $2.1 billion in 2025, then retreated by 2.32% to $2.0 billion in 2026.
  • The last three Equity Average figures came in at $2.0 billion (Q2 2026), $2.2 billion (Q1 2026), and $2.1 billion (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 3.50 Bn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 783.14 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 3.76 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 1.01 Bn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 21.35 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 19.01 Bn
9 Abivax 94.37 Bn 94.37 Bn - 516.41 Mn
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn 2.05 Bn

Historic Data

Download Data
DateValue
Apr 3, 2026 2.05 Bn
Jan 2, 2026 2.16 Bn
Oct 3, 2025 2.10 Bn
Jul 4, 2025 2.08 Bn
Apr 4, 2025 2.19 Bn
Jan 3, 2025 2.26 Bn
Sep 27, 2024 2.20 Bn
Jun 28, 2024 2.12 Bn
Mar 29, 2024 2.20 Bn
Dec 29, 2023 2.31 Bn
Sep 29, 2023 2.44 Bn
Jun 30, 2023 2.54 Bn
Mar 31, 2023 2.52 Bn
Dec 30, 2022 2.49 Bn
Sep 30, 2022 2.44 Bn
Jul 1, 2022 2.34 Bn
Apr 1, 2022 2.25 Bn
Dec 31, 2021 2.16 Bn
Oct 1, 2021 2.08 Bn
Jul 2, 2021 1.98 Bn